You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma

Article metrics

Article menu

Download PDFPDF

XML
Immunotherapy biomarkers
Original research
Development and validation of the immune signature to predict distant metastasis in patients with nasopharyngeal carcinoma

 

Online download statistics by month:

Online download statistics by month: April 2020 to September 2024

AbstractFullPdf
Apr 2020259259154
May 2020251251114
Jun 202011911976
Jul 2020636398
Aug 2020737340
Sep 2020818141
Oct 2020636338
Nov 2020515113
Dec 2020656534
Jan 2021858542
Feb 2021606037
Mar 2021858545
Apr 2021737330
May 2021535325
Jun 2021535325
Jul 2021464624
Aug 2021232323
Sep 2021464627
Oct 2021363636
Nov 2021454539
Dec 2021444423
Jan 2022414319
Feb 2022191912
Mar 2022474721
Apr 2022575934
May 2022414220
Jun 2022515119
Jul 2022536425
Aug 2022323225
Sep 2022303213
Oct 2022414136
Nov 2022373935
Dec 202241415
Jan 202312128
Feb 2023626218
Mar 2023303111
Apr 2023141410
May 2023171711
Jun 2023181911
Jul 2023151512
Aug 2023343412
Sep 202329298
Oct 2023161610
Nov 202321217
Dec 2023323313
Jan 2024222217
Feb 2024252520
Mar 2024282841
Apr 2024282821
May 2024212110
Jun 2024202017
Jul 2024414212
Aug 202413145
Sep 2024171816
Total267927051538